2023
DOI: 10.1021/scimeetings.3c01327
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

HND-01, a F-substituted dasatinib as a potent inhibitor of wild type & C481S mutant BTK with potent anti-tumor activity through modifying dasatinib major circulating metabolite in human plasma

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles